CG Labz
Peptide Library / Recovery / Healing

KLOW Blend (KPV + TB-500 + BPC-157 + GHK-Cu)

Advanced Recovery Blend

KLOW Blend (KPV + TB-500 + BPC-157 + GHK-Cu) Research Protocol

Complete Research Guide 4 min read2 peer-reviewed references

Quickstart Overview

KLOW is a four-peptide blend layering the anti-inflammatory tripeptide KPV onto the Glow recovery/skin matrix (TB-500 + BPC-157 + GHK-Cu). It targets inflammation suppression, tissue repair and collagen remodelling in a single vial.

Reconstitution
Add 3.0 mL bacteriostatic water to the 80 mg blend vial
Blend
TB-500 10 + BPC-157 10 + GHK-Cu 50 + KPV 10 mg
Measuring Reference
Dose by total blend volume — see label
Frequency
Once daily
Route (studies)
Subcutaneous
Cycle
4–8 weeks

Scientific Data

Molecular Formula
—
Molecular Weight
—
Sequence
TB-500 10 + BPC-157 10 + GHK-Cu 50 + KPV 10 mg
Sequence Length
15
CAS
Research compound
Peptide Family
Blend
Half-life
Refer to published literature
Solubility
Bacteriostatic water, sterile saline
Storage
Lyophilized: -20°C. Reconstituted: 2–8°C, use within 2–4 weeks.
Appearance
White lyophilized powder
Standard: 80 mg vial · 3 mL diluent

Dosing & Reconstitution Guide

Interactive Reconstitution
Adjust vial size, diluent and target dose. Results update live.
Full Precision Calculator →
Concentration
26.67 mg/mL
Draw Volume
0.037 mL
Syringe Units
3.8 U
Doses / Vial
80

Units assume a U-100 insulin syringe (100 units = 1 mL). KLOW = Glow + KPV; adds an anti-inflammatory arm to the recovery/skin base.

Frequency: Once daily

Reconstitution Steps

  1. 1Allow the lyophilized vial and bacteriostatic water to reach room temperature (~15 min).
  2. 2Swab both vial stoppers with a fresh 70% isopropyl alcohol pad and let them dry.
  3. 3Draw 3.0 mL of bacteriostatic water into a mixing syringe.
  4. 4Insert at an angle and let the water run slowly down the glass wall — never directly onto the powder.
  5. 5Gently swirl (do not shake) until the solution is completely clear.
  6. 6Label with date and concentration (mg/mL) and refrigerate at 2–8 °C immediately.

Supplies Needed

Planning example for a 8-week protocol at approximately 1000 mcg per day.

Peptide (80 mg vials)
Estimate vials from total mass: 1000 mcg/day × 56 days.
Bacteriostatic Water
One 10–30 mL vial typically covers a full cycle.
Insulin Syringes (U-100)
One per administration (29–31 G, 0.3–0.5 mL).
Alcohol Swabs
Two per administration (vial + site).
Sharps Container
Required for safe disposal.

Protocol Overview

Goal
Model comprehensive four-peptide recovery.
Schedule
Daily, 4–8 weeks.
Dose Range
Per blend label.

Dosing Protocol

Standard
Once daily per label ratio
Frequency
Daily, 4–8 weeks
Note
Blend mass ~80 mg (TB10+BPC10+GHK50+KPV10)
Cycle Length
4–8 weeks
Timing
Evening common
Route
Subcutaneous

Storage Instructions

Lyophilized
−20 °C long term (18–24 months); stable at room temperature for short transit.
Reconstituted
2–8 °C refrigerated; use within 4 weeks.
Light
Protect from direct light; keep in the original carton.
Freeze/Thaw
Avoid repeat freeze–thaw cycles after reconstitution.

Important Notes

  • The most complex blend here — dose attribution per compound is approximate.
  • GHK-Cu stings and tints the solution blue.

How This Works

KPV suppresses NF-κB-driven inflammation; BPC-157 and TB-500 drive local and systemic tissue repair and angiogenesis; GHK-Cu remodels collagen and resets skin gene expression. KLOW therefore addresses four arms of recovery — anti-inflammatory, local repair, systemic migration and connective-tissue remodelling — which is why it is used in comprehensive recovery research.

Potential Benefits & Side Effects

Reported in research
  • Four-way action: anti-inflammatory + repair + angiogenesis + collagen remodelling
  • Reduced inflammation alongside tissue regeneration
  • Improved skin and connective-tissue quality
  • Comprehensive recovery profile
Possible considerations
  • GHK-Cu injections sting — inject slowly
  • Transient fatigue (TB-500)
  • Injection-site reactions
  • Complex blend complicates dose attribution

Lifestyle Factors

  • Adequate hydration and 7–9 h of sleep are standard controls in most research protocols.
  • Consistent dose timing improves the reliability of any self-tracked endpoints.
  • Maintain a clean, sterile workflow for every draw to avoid contamination.

Injection Technique

  1. 1Wash hands, then prep the vial top and the target site with separate alcohol swabs.
  2. 2Pinch a subcutaneous skin fold (abdomen, ~2 inches from the navel) and insert at 45–90°.
  3. 3Depress the plunger slowly over 3–5 seconds, hold 5 seconds, then withdraw.
  4. 4Rotate sites each administration and dispose of the syringe in a sharps container.

Frequently Asked Questions

Third-party HPLC testing

CG Labz Verified Batches

No published batches yet.

Research Disclaimer

All compounds are supplied strictly for laboratory research. Dosing figures below summarize ranges reported in published preclinical and clinical literature for reference purposes only. CG Labz does not provide medical advice or individualized dosing recommendations.

Peer-reviewed literature

References

  1. [1] Gastroenterology
    Dalmasso G. et al. KPV anti-inflammatory uptake.
    View Source
  2. [2] BioMed Research International
    Pickart L. et al. GHK-Cu regenerative actions.
    View Source